Analyst Price Targets — MGTX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 27, 2026 10:56 am | — | Piper Sandler | $26.00 | $7.62 | TheFly | MeiraGTx price target lowered to $26 from $30 at Piper Sandler |
| November 24, 2025 11:12 am | Mitchell Kapoor | H.C. Wainwright | $20.00 | $7.46 | TheFly | MeiraGTx initiated with a Buy at H.C. Wainwright |
| November 14, 2025 1:31 pm | Lisa Walter | RBC Capital | $16.00 | $8.35 | StreetInsider | MeiraGTx Holdings plc (MGTX) PT Raised at RBC Capital Amid LLY Deal |
| August 13, 2024 9:40 am | Luca Issi | RBC Capital | $9.00 | $4.02 | TheFly | MeiraGTx price target lowered to $9 from $11 at RBC Capital |
Latest News for MGTX
MeiraGTx Holdings plc (MGTX) Discusses 3-Year Phase I Data on AAV-hAQP1 for Radiation-Induced Xerostomia and Commercial Opportunity Transcript
XLRP is a severe, progressive genetic eye disease causing early-onset night blindness and peripheral vision loss, leading to legal blindness by age 40–45.
LONDON and NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced the pricing of an underwritten offering of 11,111,111 of its ordinary shares at an offering price of $9.00 per share. Gross proceeds to MeiraGTx from the offering are expected to be approximately $100 million, before deducting underwriting…
LONDON and NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced that it has entered into an asset purchase agreement with Johnson & Johnson* (J&J) to acquire all interests in bota-vec for the treatment of XLRP.
LONDON and NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced positive three-year data from the completed Phase 1 AQUAx study of AAV-hAQP1 for the treatment of grade 2/3 late radiation-induced xerostomia (RIX).
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MGTX.
U.S. House Trading
No House trades found for MGTX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.